410 likes | 641 Views
Burden of the Diseases. Dramatic shift in the distribution of deaths from younger to older ages from Group I diseases (communicable, maternal, perinatal and nutritional) to non-communicable disease (Group II) The proportion of deaths due to non-communicable disease is projected to rise from 59
E N D
1. Implementation of National Cancer Control Programs A.Murat TUNCER MD Director, Cancer Control Department, MoH
2. Burden of the Diseases Dramatic shift in the distribution of deaths
from younger to older ages
from Group I diseases (communicable, maternal, perinatal and nutritional) to non-communicable disease (Group II)
The proportion of deaths due to non-communicable disease is projected to rise from 59% in 2002 to 66% in 2030
4. Cancer Risk Factors Smoking
Number of the smokers
2010 1.4 billion
2020 1.6 billion
2030 1.8 billion
Ageing
Number of people aged 60 years and above
2010 0.8 billion (11.2 %)
2020 1 billion (13.6 %)
2030 1.4 billion (16.7 %)
Obesity
Percentage of obese people in Europe
2010 15-28 %
2020 19-35 %
2030 23-43 %
5. Cancer Burden in Europe(Ferlay et al. 2007) EU25; 2.3 million new cases, 1 million deaths
Continent;3.2 million new cases, 1,7 million deaths (55% men)
Lung+prostate+breast+colorectal>50% incidence, >45% mortality
Male; Lung, prostate, colon-rectum, stomach, bladder
Female; Breast, colon-rectum, lung, stomach, ovary
6. Geographical Variations Two-fold range in age-adjusted incidence and mortality in man and 1.5-fold in women
Highest overall cancer incidence rates in men; Hungary
Highest overall cancer incidence rates in women; Denmark and Iceland
18. Pharmacetical expenditure (% of total exp)
19. Physician per 1.000 p
21. Chemotherapy for advanced cancer
23. International policies and instruments for primary prevention and health promotion General
Europe Code against Cancer (2003 – being updated)
Alcohol
WHO Resolution on framework for alcohol policy
EU Alcohol strategy
European Alcohol and Health Forum
Nutrition
WHO food and nutrition action plan
Global Strategy on Diet and Physical Activity
EU White Paper on Strategy for Europe on nutrition overweight and Obesity
EU Platform for action on Diet, Physical Activity and Health
Tobacco
EU Directives on advertising and product regulation
Green Paper on Smoke-free environment
WHO Framework Convention on Tobacco Control
HELP campaign
Environment
European Environment and Health Strategy
European Environment and Health Action plan 2004-2010
Health and safety at work strategy
Other policies and instruments
Free movement and pricing of unhealthy products, consumer protection, environmental policy, etc.
24. The European Code Against Cancer Do not smoke
Avoid obesity
Moderate physical exercise every day
Increase daily intake and variety of fruit and vegatables
If you drink alcohol do so in moderation
Avoid excessive sun exposure Stricktly apply the legislation designed to prevent any exposure to carcinogenic substances
Women over 25 should participate in cervical screening
Women over 50 should participate in breast screening
Men and women over 50 should participate in colon screening
Participate in vaccination programmes against hepatitis B
25. Cancer Screening Issues Earlier detection ; higher survival chances.
Screening: opportunistic, selective, organised, population based,national , regional, pilot studies
(Variety of approaches throughout the EU, not all of them are equally effective!)
26. Cervical cancer screeening in Europe National-population based
UK
Norvey,Finland,Sweden,Denmark,Netherland
Hungary
Slovenia,Latvia
Regional Screening
Spain,Portugal,Italy,Romania,Austria,Czhec Republic,Belgium
Pilot Programs
France,Greece,Ireland,Estonia
No National Population Based Program
Germany
27. Cervical cancer screening in Europe Slovenia %30 coverage
Scandinavian countries %100
Not younger than 20, not older than 35
Stop at 60-70
Intervals and policies are different
28. Screening for breast cancer 50-69 years, two-year interval
Northern European countries participation 80%, recall rates 1-8%
Consistent mortality reduction 20-35%
Sweden 15-20 years 12-18%
Edinburgh,Scotland 14 years 21%
29. Screening for colorectal cancer 50-74 age group
two specimens on three consecutive days(FOB)
one and two-year screening intervals
meta-analysis(Towler et al,1998); 6-18%reduction in mortality
Nottingham trial
there was no reduction in incidence
significant reduction (19%) in mortality
Danish study
14% mortality reduction
Finland; 1/3 population covered in 2007
France, Italy, Netherlands, Poland, UK; Regional initiatives implementation
30. BULDING BLOCKS of CANCER’S FUTURE
31. Organisation Health Authority ; Ministry of Health(MoH)
Drug and pharmacy; Prices and certifications
Treatment services; Hospitals
Cancer Control Department; Cancer Control Program
Public Health: Nutritional habits and control of the market, tobacco control and quitting/cessation programs,healthy life style,physical activity
Collaboration;
Education; Ministry of Education (Higher Education Council -Universities), NGOs
Research projects (some): State Planning Department (DPT) and Turkish Scientific and Technical Council (TUBITAK)
Finance ; Ministry of Finance, Department of Tresury
33. Cancer Mortality: Turkey (ASR/World per 100,000; Source: Globocan 2002)
34. Human Resources(for 150.000 new cases/yearDoctors per 1.000 pop: 1.2) Medical Oncologist 175
Pediatric Oncologist 97
Radiation Oncologist 306
Pathologist 800
Radiation Physicist 88
Oncology Nurse 525
Physcolog 50
Social Workers 23
35. International papers related with cancer
41. Strategic Approach Reduce inequity
Improve cancer services
Resources
Clinical guidelines
Systematic training
Accreditation
Monitoring
Increase prevention and early diagnosis
Education
Reduce avoidable premature deaths
(150.000 12% ;EU)
Budget and investment
human resources, capacity building, substructur
Priorities of the problems
Differences and similarities
National cancer research strategy
Original and cost-benefit studies
Implement policies, strategies and plans
Collaboration/cooperation/
organisation
Govermental responsibility
42. WHO GLOBAL ACTION PLAN SEVEN COMPONENTS 1.Advocate for cancer prevention, cure and care
2.Promote WHO strategies impacting on cancer
3.Promote National Cancer Control Programmes (NCCP) in countries based on the four goals and multiple strategies approach
4.Support NCCP development and implamentation in High Burden Low and Middle Income Countries (LMCs)
5.Monitor implementation and impact of national and global interventions:the WHO Cancer Surveillance Project.
6.Develop WHO Technical Advisory Committee on Cancer
7.Develop concultation process to identify research priorities to support Action Plan.